METROPOLITAN LIFE INSURANCE CO/NY - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 94 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$110,943
-13.8%
2,1000.0%0.00%0.0%
Q2 2020$128,688
+8.3%
2,1000.0%0.00%
-33.3%
Q1 2020$118,797
-0.6%
2,1000.0%0.00%
+50.0%
Q4 2019$119,574
+6.4%
2,1000.0%0.00%0.0%
Q3 2019$112,392
-10.4%
2,1000.0%0.00%0.0%
Q2 2019$125,391
-4.2%
2,1000.0%0.00%0.0%
Q1 2019$130,893
+2.9%
2,1000.0%0.00%
-33.3%
Q4 2018$127,260
+3.6%
2,1000.0%0.00%
+50.0%
Q3 2018$122,829
+25.3%
2,100
-6.9%
0.00%
+100.0%
Q4 2017$98,000
-56.1%
2,256
-49.9%
0.00%
-50.0%
Q2 2017$223,000
-9.7%
4,5000.0%0.00%0.0%
Q1 2017$247,000
-1.6%
4,5000.0%0.00%0.0%
Q4 2016$251,000
+21.8%
4,5000.0%0.00%0.0%
Q3 2016$206,000
+14.4%
4,5000.0%0.00%
+100.0%
Q2 2016$180,000
+36.4%
4,500
+19.0%
0.00%0.0%
Q1 2016$132,000
-19.0%
3,7820.0%0.00%0.0%
Q4 2015$163,000
-1.2%
3,7820.0%0.00%0.0%
Q3 2015$165,000
-15.4%
3,7820.0%0.00%0.0%
Q2 2015$195,0003,7820.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q3 2018
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 82,800$2,468,0003.37%
NORTHPOINTE CAPITAL LLC 123,764$4,845,0000.52%
EAM Investors, LLC 78,901$3,089,0000.36%
Elk Creek Partners, LLC 83,357$3,263,0000.34%
TFS CAPITAL LLC 68,551$2,684,0000.26%
Ativo Capital Management LLC 13,075$512,0000.20%
RICE HALL JAMES & ASSOCIATES, LLC 58,623$2,295,0000.13%
Hillsdale Investment Management Inc. 10,480$410,0000.10%
GSA CAPITAL PARTNERS LLP 63,647$2,492,0000.10%
Palo Alto Investors LP 50,436$1,975,0000.10%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders